Tinengotinib in patients with advanced solid tumors harboring actionable FGFR1-3 mutations

被引：0
|
作者：
Piha-Paul, Sarina A.
Liao, Chih-Yi Andy
Fonkoua, Lionel
Mahipa, Amit, I
Goel, Sanjay
Fountzilas, Christos
Shen, Lin
Li, Daneng
Deming, Dustin
Dayyani, Farshid
Han, Weiqing
Niu, Zuoxing
Fan, Jean
Peng, Peng
Wang, Hui
Huang, Peng
Wu, Frank
Javle, Milind
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-LB162
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB162
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Non-small cell lung cancer (NSCLC) patients harboring mutations in FGFR2 and FGFR3: clinical and genomic features
    Scheffler, M.
    Chanra, T.
    Kron, A.
    Koleczko, S.
    Abdulla, D. S. Y.
    Ihle, M. A.
    Riedel, R.
    Michels, S.
    Fischer, R.
    Merkelbach-Bruse, S.
    Buettner, R.
    Nogova, L.
    Wolf, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 112 - 112
  • [42] Genomic and clinical characterization of non-small cell lung cancer (NSCLC) patients harboring mutations in FGFR2 and FGFR3
    Scheffler, M.
    Chanra, T.
    Kron, A.
    Koleczko, S.
    Abdulla, D. S. Y.
    Ihle, M. A.
    Holzem, A.
    Riedel, R.
    Michels, S.
    Fischer, R. N.
    Merkelbach-Bruse, S.
    Buettner, R.
    Nogova, L.
    Wolf, J.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] First in human (FIH) phase 1/1b study evaluating KIN-3248, a next-generation, irreversible pan-FGFR inhibitor (FGFRi), in patients (pts) with advanced urothelial carcinoma (UC) and other solid tumors harboring FGFR2 and/or FGFR3 gene alterations.
    Garmezy, Benjamin
    Perez, Cesar Augusto
    Kato, Shumei
    Sharma, Manish
    Quah, Cheng Seok
    Tam, Betty
    Severson, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [44] A phase II open-label study in adult and adolescent patients (pts) with advanced solid tumors harboring fibroblast growth factor receptor (FGFR) gene alterations.
    Pant, Shubham
    Tabernero, Josep
    Massard, Christophe
    Iyer, Gopa
    Witt, Olaf
    Doi, Toshihiko
    Qin Shukui
    Lu-Emerson, Christine
    Hargrave, Darren R.
    Garcia-Corbacho, Javier
    Little, Shonda Marie
    Xia, Qi
    Santiago-Walker, Ademi E.
    Moy, Christopher
    Hammond, Constance
    Sweiti, Hussein
    Schuler, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [45] First-in-human phase I study of TT-00434, an orally available FGFR (1-3) inhibitor in patients with advanced solid tumors
    Yen, C. J.
    Liu, M-C.
    Fan, J.
    Sun, C.
    Peng, P.
    Du, X.
    Wang, J.
    Wei, F.
    Gou, Z.
    Tan, X.
    Wu, D.
    Wu, F.
    Ho, C-L.
    ANNALS OF ONCOLOGY, 2023, 34 : S1497 - S1497
  • [46] Adagrasib in Advanced Solid Tumors Harboring a KRASG12C Mutation
    Bekaii-Saab, Tanios S.
    Yaeger, Rona
    Spira, Alexander I.
    Pelster, Meredith S.
    Sabari, Joshua K.
    Hafez, Navid
    Barve, Minal
    Velastegui, Karen
    Yan, Xiaohong
    Shetty, Aditya
    Der-Torossian, Hirak
    Pant, Shubham
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (25) : 4097 - +
  • [47] Infigratinib, a selective FGFR1-3 tyrosine kinase inhibitor, alters dentoalveolar development at high doses
    Michel, Zachary D.
    Aitken, Sarah F.
    Glover, Omar D.
    Alejandro, Lucy O.
    Randazzo, Davide
    Dambkowski, Carl
    Martin, David
    Collins, Michael T.
    Somerman, Martha J.
    Chu, Emily Y.
    DEVELOPMENTAL DYNAMICS, 2023, 252 (12) : 1428 - 1448
  • [48] Characterization of FGFR1, FGFR2 and FGFR3 mutations in 45 Brazilian patients with craniosynostosis.
    Passos-Bueno, MR
    Sertié, AL
    Richieri-Costa, A
    Alonso, LG
    Zatz, M
    Alonson, N
    Brunoni, D
    Ribeiro, SFM
    Cavalheiro, S
    AMERICAN JOURNAL OF HUMAN GENETICS, 1997, 61 (04) : A342 - A342
  • [49] Evaluating larotrectinib for the treatment of advanced solid tumors harboring an NTRK gene fusion
    Filippi, Roberto
    Depetris, Ilaria
    Satolli, Maria Antonietta
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (06) : 677 - 684
  • [50] The distribution of FGFR3 mutations in bladder tumors of different stages
    Bresam, Sabah
    Altae, Bashar Ouda
    AlFaisal, Abdul Hussein M.
    BIOSCIENCE RESEARCH, 2019, 16 (01): : 95 - 101
12345